Mammalian Target of Rapamycin Inhibitors for Intractable Epilepsy and Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex
Michael Cardamone(UNSW Sydney), John A. Lawson(Universities UK), Maya Chopra(Boston Children's Hospital), David Mowat(UNSW Sydney), Seán Kennedy(Environmental Protection Agency), Danny Flanagan(UNSW Sydney)
Cited by 151
Related Papers
Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
|Pediatric Neurology|2013|1.5k
Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
|Pediatric Neurology|2013|863
Biomarkers of Oxidative Stress Study II: Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?
|Free Radical Biology and Medicine|2004|697
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
|Journal of Clinical Investigation|1983|671